During the last session, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s traded shares were 0.32 million, with the beta value of the company hitting 1.81. At the
In the last trading session, 1.53 million shares of the Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) were traded, and its beta was 1.82. Most recently the
In the last trading session, 4.69 million shares of the Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) were traded, and its beta was 1.77. Most recently the
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s traded shares stood at 161.07 million during the last session, with the company’s beta value hitting 1.82. At the close
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s traded shares stood at 83.31 million during the latest session, with the company’s beta value hitting 1.82. At the last
In last trading session, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) saw 0.57 million shares changing hands with its beta currently measuring 1.83. Company’s recent per share
In last trading session, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) saw 1.94 million shares changing hands with its beta currently measuring 1.83. Company’s recent per share
During the last session, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s traded shares were 1.77 million, with the beta value of the company hitting 1.83. At the
In the last trading session, 1.13 million shares of the Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) were traded, and its beta was 1.83. Most recently the
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s traded shares stood at 0.84 million during the last session, with the company’s beta value hitting 1.83. At the close
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
